 Papillomavirus Vaccines
"Papillomavirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
| Descriptor ID |
D053918
|
| MeSH Number(s) |
D20.215.894.899.498
|
| Concept/Terms |
Human Papillomavirus Vaccines- Human Papillomavirus Vaccines
- Papillomavirus Vaccines, Human
- Vaccines, Human Papillomavirus
- Human Papilloma Virus Vaccines
- HPV Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Papillomavirus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Vaccines".
This graph shows the total number of publications written about "Papillomavirus Vaccines" by people in this website by year, and whether "Papillomavirus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 | | 2008 | 3 | 1 | 4 | | 2009 | 1 | 0 | 1 | | 2010 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 3 | 0 | 3 | | 2013 | 2 | 0 | 2 | | 2014 | 2 | 0 | 2 | | 2017 | 2 | 0 | 2 | | 2019 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Papillomavirus Vaccines" by people in Profiles.
-
Galliverti G, Wullschleger S, Tichet M, Murugan D, Zangger N, Horton W, Korman AJ, Coussens LM, Swartz MA, Hanahan D. Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers. Cancer Immunol Res. 2020 01; 8(1):131-145.
-
Montalto GJ. Sexually Transmitted Infections: Prevention, Diagnosis, and Treatment in Primary Care. Pediatr Ann. 2019 Sep 01; 48(9):e370-e375.
-
Saulsberry L, Fowler EF, Nagler RH, Gollust SE. Perceptions of politicization and HPV vaccine policy support. Vaccine. 2019 08 14; 37(35):5121-5128.
-
Teteh DK, Dawkins-Moultin L, Robinson C, LaGroon V, Hooker S, Alexander K, Kittles RA. Use of community forums to increase knowledge of HPV and cervical cancer in African American communities. J Community Health. 2019 06; 44(3):492-499.
-
Hoefer L, Tsikis S, Bethimoutis G, Nicolaidou E, Paparizos V, Antoniou C, Kanelleas A, Chardalias L, Stavropoulos GE, Schneider J, Charnot-Katsikas A. HPV vaccine acceptability in high-risk Greek men. Hum Vaccin Immunother. 2018 01 02; 14(1):134-139.
-
Krantz L, Ollberding NJ, Beck AF, Carol Burkhardt M. Increasing HPV Vaccination Coverage Through Provider-Based Interventions. Clin Pediatr (Phila). 2018 03; 57(3):319-326.
-
Cifu AS, Davis AM. Use of HPV vaccine in males and females. JAMA. 2014 Nov 12; 312(18):1920-1.
-
Quinn GP, Vadaparampil ST, Johns T, Alexander KA, Giuliano AR. Adolescent sexual activity and cancer risk: physicians' duty to inform? Curr Med Res Opin. 2014 Sep; 30(9):1827-31.
-
Harper DM, Verdenius I, Ratnaraj F, Arey AM, Rosemergey B, Malnar GJ, Wall J. Quantifying clinical HPV4 dose inefficiencies in a safety net population. PLoS One. 2013; 8(11):e77961.
-
Smith JS, Brewer NT, Saslow D, Alexander K, Chernofsky MR, Crosby R, Derting L, Devlin L, Dunton CJ, Engle J, Fernandez M, Fouad M, Huh W, Kinney W, Pierce J, Rios E, Rothholz MC, Shlay JC, Shedd-Steele R, Vernon SW, Walker J, Wynn T, Zimet GD, Casey BR. Recommendations for a national agenda to substantially reduce cervical cancer. Cancer Causes Control. 2013 Aug; 24(8):1583-93.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|